Medicare Enrolled
Dr. Asadulla Mohammed, MD
Pulmonary Disease · Berkley, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mohammed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohammed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mohammed
Dr. Asadulla Mohammed is a pulmonary disease specialist in Berkley, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mohammed performed 6,192 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mohammed received a total of $99,527 from 49 pharmaceutical and/or device companies across 937 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mohammed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in MI
$99,527 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,192
Medicare services
Top 2% in MI for pulmonary disease
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,280 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $97 | $165 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
614 | $39 | $102 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
595 | $96 | $140 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
485 | $48 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
417 | $31 | $71 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
413 | $39 | $112 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
247 | $65 | $111 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
174 | $61 | $95 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
147 | $42 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
147 | $44 | $98 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
145 | $30 | $105 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
143 | $139 | $300 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
84 | $15 | $33 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
78 | $137 | $224 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $122 | $254 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
69 | $44 | $98 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
59 | $25 | $119 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
49 | $64 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $10 | $45 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
34 | $488 | $995 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
33 | $33 | $36 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
33 | $31 | $35 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
31 | $56 | $71 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $82 | $167 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
19 | $40 | $62 |
| New patient office visit, complex (60-74 min) | 17 | $165 | $318 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
12 | $473 | $894 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$99,527
Total received (2018-2024)
Avg $14,218/year across 7 years
Top 2% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
937
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$21,239
2023
$25,171
2022
$16,028
2021
$9,997
2020
$8,304
2019
$7,307
2018
$11,480
Payments by company (2024)
Actelion Pharmaceuticals US, Inc.
$18,812
AstraZeneca Pharmaceuticals LP
$433
Amgen Inc.
$327
GlaxoSmithKline, LLC.
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$161
Grifols USA, LLC
$119
Bayer Healthcare Pharmaceuticals Inc.
$112
GENZYME CORPORATION
$111
Regeneron Healthcare Solutions, Inc.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$100
Mylan Specialty L.P.
$98
Azurity Pharmaceuticals, Inc.
$93
Avadel CNS Pharmaceuticals, LLC
$84
United Therapeutics Corporation
$84
JAZZ PHARMACEUTICALS INC.
$71
Mallinckrodt Hospital Products Inc.
$60
Merck Sharp & Dohme LLC
$57
Inspire Medical Systems, Inc.
$38
Genentech USA, Inc.
$32
Pulmonx Corporation
$24
ANI Pharmaceuticals, Inc.
$23
Paratek Pharmaceuticals, Inc.
$22
INOGEN, INC.
$22
Resmed Corp
$21
Top 3 companies account for 92.2% of 2024 payments
All-time payments by company (2018-2024) ›
Actelion Pharmaceuticals US, Inc.
$82,783
AstraZeneca Pharmaceuticals LP
$1,918
GlaxoSmithKline, LLC.
$1,880
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,693
Mylan Specialty L.P.
$1,376
Actelion Pharmaceuticals, Ltd
$1,224
Inspire Medical Systems, Inc.
$954
Sunovion Pharmaceuticals Inc.
$684
United Therapeutics Corporation
$642
Grifols USA, LLC
$637
Regeneron Healthcare Solutions, Inc.
$623
Amgen Inc.
$504
Takeda Pharmaceuticals U.S.A., Inc.
$493
GENZYME CORPORATION
$430
Electromed, Inc.
$405
JAZZ PHARMACEUTICALS INC.
$348
Genentech USA, Inc.
$251
Teva Pharmaceuticals USA, Inc.
$246
Harmony Biosciences LLC
$235
Mallinckrodt Hospital Products Inc.
$200
Insmed, Inc.
$189
Advanced Respiratory, Inc
$169
Bayer Healthcare Pharmaceuticals Inc.
$166
Pulmonx Corporation
$128
Philips Electronics North America Corporation
$124
Bayer HealthCare Pharmaceuticals Inc.
$117
Circassia Pharmaceuticals Inc
$115
Azurity Pharmaceuticals, Inc.
$93
Paratek Pharmaceuticals, Inc.
$91
Avadel CNS Pharmaceuticals, LLC
$84
Mallinckrodt Enterprises LLC
$81
Merck Sharp & Dohme LLC
$75
Gilead Sciences, Inc.
$69
Veran Medical Technologies, Inc.
$55
Shire North American Group Inc
$55
HARMONY BIOSCIENCES LLC
$48
Eisai Inc.
$44
ADVANCED RESPIRATORY, INC
$43
Baxter Healthcare
$39
Novartis Pharmaceuticals Corporation
$37
PFIZER INC.
$34
ANI Pharmaceuticals, Inc.
$23
INOGEN, INC.
$22
Resmed Corp
$21
Allergan Inc.
$20
Xeris Pharmaceuticals, Inc.
$17
Jazz Pharmaceuticals Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$14
Alnylam Pharmaceuticals Inc.
$12
Top 3 companies account for 87.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · Disposable Vest · Dymista · Esbriet · FASENRA · GLASSIA · HORIZANT · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · Inspire Upper Airway Stimulation System · KEVEYIS · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · NIOX VERO · NUCALA · NUZYRA · OFEV · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · REMODULIN · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Spin · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
113
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL ROYAL OAK
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mohammed is a clinical cardiology specialist, with above-average Medicare volume (top 2% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mohammed experienced with allergy skin test?
Based on Medicare claims data, Dr. Mohammed performed 1,280 allergy skin test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mohammed receive payments from pharmaceutical companies?
Yes. Dr. Mohammed received a total of $99,527 from 49 companies across 937 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohammed's costs compare to other pulmonary diseases in Berkley?
Dr. Mohammed's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohammed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Berkley
Browse pulmonary diseases in Berkley ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology